home.social

#biopharmaceuticals — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #biopharmaceuticals, aggregated by home.social.

  1. How I Built a Machine Learning Tool to Predict Drug Manufacturing Failures

    A bioprocess engineer's journey into machine learning and why the pharmaceutical industry desperately needs this bridge When I tell people I work in bioprocess engineering, I usually get blank stares. When I explain that I help manufacture proteins in giant tanks for therapeutic use, the response is often: "Oh, like brewing beer?" Not quite. But close enough. What I don't usually mention is that I've been teaching myself machine learning on nights and weekends. Not because it's trendy, but […]

    kemal.yaylali.uk/from-bioreact

  2. From Bioreactors to AI: How I Built a Machine Learning Tool to Predict Drug Manufacturing Failures

    *A bioprocess engineer's journey into machine learning—and why the pharmaceutical industry desperately needs this bridge* --- When I tell people I work in bioprocess engineering, I usually get blank stares. When I explain that I help manufacture proteins in giant tanks for therapeutic use, the response is often: "Oh, like brewing beer?" Not quite. But close enough. The $50 Million Problem Nobody Talks About What I don't usually mention is that I've been teaching myself machine learning […]

    kemal.yaylali.uk/from-bioreact

  3. From Bioreactors to AI: How I Built a Machine Learning Tool to Predict Drug Manufacturing Failures

    *A bioprocess engineer's journey into machine learning—and why the pharmaceutical industry desperately needs this bridge* --- When I tell people I work in bioprocess engineering, I usually get blank stares. When I explain that I help manufacture proteins in giant tanks for therapeutic use, the response is often: "Oh, like brewing beer?" Not quite. But close enough. The $50 Million Problem Nobody Talks About What I don't usually mention is that I've been teaching myself machine learning […]

    kemal.yaylali.uk/from-bioreact

  4. Celltrion has completed its acquisition of a New Jersey biopharmaceutical plant from Eli Lilly, aiming to reduce US tariff risks and expand its US market presence, with plans for major capacity investment and a $473 million supply contract.
    #YonhapInfomax #Celltrion #EliLilly #TariffRisks #Biopharmaceuticals #NewJerseyFacility #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
    en.infomaxai.com/news/articleV

  5. Celltrion has completed its acquisition of a New Jersey biopharmaceutical plant from Eli Lilly, aiming to reduce US tariff risks and expand its US market presence, with plans for major capacity investment and a $473 million supply contract.
    #YonhapInfomax #Celltrion #EliLilly #TariffRisks #Biopharmaceuticals #NewJerseyFacility #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
    en.infomaxai.com/news/articleV

  6. Celltrion has completed its acquisition of a New Jersey biopharmaceutical plant from Eli Lilly, aiming to reduce US tariff risks and expand its US market presence, with plans for major capacity investment and a $473 million supply contract.
    #YonhapInfomax #Celltrion #EliLilly #TariffRisks #Biopharmaceuticals #NewJerseyFacility #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
    en.infomaxai.com/news/articleV

  7. SK Plasma and Aimed Bio have entered a joint development and licensing agreement to co-develop an ADC-based cancer drug, combining Aimed Bio's research with SK Plasma's clinical and commercialization expertise to target rare and intractable diseases.
    #YonhapInfomax #SKPlasma #AimedBio #ADCTherapy #CancerDrug #Biopharmaceuticals #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
    en.infomaxai.com/news/articleV